ArticleExperimental and clinical cardiology2010
Drugs in pregnancy: Implications for a cardiologist.
Article in Experimental and clinical cardiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Preconception Counseling for Women With Cardiac Disease.Current treatment options in cardiovascular medicine · 2017Review
- Use of medication for cardiovascular disease during pregnancy.Nature reviews. Cardiology · 2015Review
- Reduction in mortality and teratogenicity following simultaneous administration of folic acid and vitamin E with antiepileptic, antihypertensive and anti-allergic drugs.Journal of pharmacy & bioallied sciences · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The safe use of drugs during pregnancy depends on several factors including the time of application, the type of drug and its dose. In the present review, the effect of certain therapeutic drugs on pregnancy is first described using general principles, followed by a more focused discussion on the type of adverse effects related to specific cardiovascular drugs used during pregnancy. In particular, adverse events related to the use of antihypertensive and antiarrhythmic drugs and anticoagulants are described, followed by the characterization of congenital cardiovascular defects resulting from the use of various drugs during pregnancy. Finally, various methods used to obtain information on the topic are described, and the need for carefully designed clinical trials is stressed.
Indexed as
Identifiers
21264066PMC3016068What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.